We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metabolomic in Critical Ill Patients

This study is currently recruiting participants.
Verified March 2017 by Giovanni Landoni, Università Vita-Salute San Raffaele
Sponsor:
ClinicalTrials.gov Identifier:
NCT01506674
First Posted: January 10, 2012
Last Update Posted: March 9, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Giovanni Landoni, Università Vita-Salute San Raffaele
  Purpose
Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.

Condition
Metabolomic

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Giovanni Landoni, Università Vita-Salute San Raffaele:

Primary Outcome Measures:
  • Metabolomic patterns to identify poor outcome [ Time Frame: hospital stay (approximately two weeks) ]

Study Start Date: January 2015
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
criticall ill patients

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Critical ill patients
Criteria

Inclusion Criteria:

  • patients with severe left or right ventricular dysfunction undergoing cardiac surgery
  • patients undergoing ablation of ventricular tachycardia
  • patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases
  • patients undergoing thoracoabdominal vascular surgery

Exclusion Criteria:

  • pregnant women
  • no written consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01506674


Locations
Italy
Università Vita-Salute San Raffaele Recruiting
Milano, Mi, Italy, 20132
Contact: Giovanni Landoni       landoni.giovanni@hsr.it   
Contact: Laura Pasin       pasin.laura@hsr.it   
Sponsors and Collaborators
Università Vita-Salute San Raffaele
  More Information

Responsible Party: Giovanni Landoni, MD, Associate Professor, Università Vita-Salute San Raffaele
ClinicalTrials.gov Identifier: NCT01506674     History of Changes
Other Study ID Numbers: HSR CEmet
First Submitted: January 9, 2012
First Posted: January 10, 2012
Last Update Posted: March 9, 2017
Last Verified: March 2017